BAMBI Antibodies

Santa Cruz Biotechnology features a diverse variety of BAMBI Antibodies for advanced research in cellular signaling and development. Monoclonal BAMBI Antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BAMBI, or Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor, plays a crucial role in modulating the signaling pathways of bone morphogenetic proteins (BMPs) and transforming growth factor-beta (TGF-β). As a negative regulator, BAMBI maintains cellular homeostasis and influences processes such as cell differentiation, proliferation, and apoptosis. Understanding BAMBI function is vital for elucidating implications in various diseases, including cancer and fibrosis. Research has shown that BAMBI expression levels can vary significantly across different tissue types and developmental stages. Studying BAMBI interactions with other signaling molecules provides insights into developmental biology and disease progression. Current investigations focus on how BAMBI regulation affects various cellular pathways and its potential as a therapeutic target. Santa Cruz Biotechnology monoclonal BAMBI Antibodies enable researchers worldwide to advance their understanding of cellular processes and disease mechanisms.